1-((1H-imidazol-2-yl)methyl)-6-(4-(1-aminocyclobutyl)phenyl)-7-phenyl-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one → HCID 53262566, compound
Reaction equation
N1C=CN=C1CN1C(=O)COC2N=C(C3C=CC(C4(N)CCC4)=CC=3)C(C3C=CC=CC=3)=CC1=2.C(OC(=O)[NH:41][C:42]1([C:46]2[CH:51]=[CH:50][C:49]([C:52]3[C:53]([C:65]4[CH:70]=[CH:69][CH:68]=[CH:67][CH:66]=4)=[CH:54][C:55]4[N:61]([CH3:62])[C:60](=[O:63])[CH2:59][CH2:58][NH:57][C:56]=4[N:64]=3)=[CH:48][CH:47]=2)[CH2:45][CH2:44][CH2:43]1)(C)(C)C>>[NH2:41][C:42]1([C:46]2[CH:47]=[CH:48][C:49]([C:52]3[C:53]([C:65]4[CH:66]=[CH:67][CH:68]=[CH:69][CH:70]=4)=[CH:54][C:55]4[N:61]([CH3:62])[C:60](=[O:63])[CH2:59][CH2:58][NH:57][C:56]=4[N:64]=3)=[CH:50][CH:51]=2)[CH2:43][CH2:44][CH2:45]1Participants
3
Procedure
Following the procedure for 1-((1H-imidazol-2-yl)methyl)-6-(4-(1-aminocyclobutyl)phenyl)-7-phenyl-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one, tert-butyl(1-(4-(1-methyl-2-oxo-8-phenyl-2,3,4,5-tetrahydro-1H-pyrido[2,3-b][1,4]diazepin-7-yl)phenyl)cyclobutyl)carbamate (21 mg, 0.04 mmol) was reacted to afford the title compound (19 mg, 72%). LCMS (Method D): RT=0.806 min, M+1=399. 1H NMR (500 MHz, MeOD): 7.65 (1H, s), 7.47 (2H, d), 7.41 (2H, d), 7.29-7.25 (3H, m), 7.20-7.19 (2H, m), 3.86-3.84 (4H, m), 3.41 (3H, s), 2.79-2.73 (4H, m), 2.61-2.55 (2H, m), 2.25-2.18 (1H, m), 1.99-1.91 (1H, m).
Workup
- customwas reacted
Sources & evidence
- ORD record
- ord-72b9658ca6c749f09e6432c420ff1231
- Source dataset
- uspto-grants-2015_12
- Patent number
- US09221838B2
Reaction notes
Loading…